These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7573844)

  • 1. The first 20 minutes after a single dose of inhaled salmeterol in asthmatic children.
    Barbato A; Cracco A; Tormena F; Novello A
    Allergy; 1995 Jun; 50(6):506-10. PubMed ID: 7573844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A; Svedmyr N
    Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
    Lundback B; Rawlinson DW; Palmer JB
    Thorax; 1993 Feb; 48(2):148-53. PubMed ID: 8493629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol in paediatric asthma.
    Byrnes C; Shrewsbury S; Barnes PJ; Bush A
    Thorax; 2000 Sep; 55(9):780-4. PubMed ID: 10950898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. European Study Group.
    Britton MG; Earnshaw JS; Palmer JB
    Eur Respir J; 1992 Oct; 5(9):1062-7. PubMed ID: 1426215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE; Soni NR; Watson WT; Becker AB
    J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
    van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
    Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group.
    Faurschou P; Steffensen I; Jacques L
    Eur Respir J; 1996 Sep; 9(9):1885-90. PubMed ID: 8880107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells.
    Lötvall J; Lunde H; Ullman A; Törnqvist H; Svedmyr N
    Allergy; 1992 Oct; 47(5):477-83. PubMed ID: 1362481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of salmeterol in childhood asthma.
    Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
    Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator response to salbutamol after chronic dosing with salmeterol or placebo.
    Langley SJ; Masterson CM; Batty EP; Woodcock A
    Eur Respir J; 1998 May; 11(5):1081-5. PubMed ID: 9648959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
    BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients.
    Grove A; Lipworth BJ
    Lancet; 1995 Jul; 346(8969):201-6. PubMed ID: 7616798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic effects of salbutamol and salmeterol in patients with asthma.
    Bennett JA; Smyth ET; Pavord ID; Wilding PJ; Tattersfield AE
    Thorax; 1994 Aug; 49(8):771-4. PubMed ID: 8091321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.